Icon

GOCOVRI (nda208944)- (EQ 68.5MG BASE,EQ 137MG BASE)

AMANTADINE HYDROCHLORIDE SUPERNUS PHARMS
EQ 68.5MG BASE,EQ 137MG BASE
Yes Yes
2038-Aug-23 Expired
2024-Aug-24 2020-Aug-24
None No
GOCOVRI ® is indicated: • For the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications • As adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease experiencing “off” episodes.
1 2 0
Total Other Developers 6
Drugs with Suitability No
EQ 68.5MG BASE ** ** - - -
EQ 137MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.